Search Results 1251-1260 of 27622 for autoimmune hepatitis
Hepatitis or other liver disease—There is a greater chance of side effects because the medicine is not broken down and may build up in the body; also, if ...
Hepatitis B infection, active or; Tuberculosis, active or untreated inactive ... Liver disease—Use with caution. May make this condition worse ...
Other heart conditions. Infection. Age-related changes. Autoimmune disease, such as lupus. Risk factors. Several things can increase the risk of ...
These complications are obesity, severe insulin resistance, diabetes, dyslipidemia and fatty liver disease. Understanding the underlying mechanisms of this ...
The purpose of this study is to evaluate the safety of acamprosate in individuals with alcohol-use disorder (AUD) and alcohol-related liver disease.
Liver disease—Effects of methyldopa may be increased because of slower removal from the body. If hydrochlorothiazide causes loss of too much water from the ...
Shah has maintained National Institutes for Health-funded programs at Mayo Clinic for 25 years related to advanced liver disease that cross basic science ...
Mental illness, history of—May increase the chance of having serious psychiatric side effects. Hepatitis B or; Hepatitis C or; Liver disease, mild or; QT ...
This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA) ...
This causes the body to make more red blood cells. Red blood cell counts also can be high in nonalcoholic fatty liver disease. Nonalcoholic fatty liver disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.